每日减重药片,副作用低 推动美国销售
继续阅读分类:肥胖,疾病和条件,身体和心智标记:GLP-1受体激动剂,体重损失,临床试验,脂肪细胞,肽,
Reliability 43 · moderate1 h ago
- Center1
- Right1
2 sources2 independent voices
no rewrites detected — all voices distinct
2 countries · 1 languages
综述
一种一天一次的低影响口服GLP-1药丸被称作CX11已经通过对美国病人的疗效测试,以推进北美第一期第三阶段试验.
交叉核实自 2 家媒体。
Factual coreconfirmed by several independent voices
Insufficient core: not enough independent confirmations to retain a shared fact.
Reported detailssecondary facts, each attributed to its source
一种一天一次的低影响口服GLP-1药丸被称作CX11已经通过对美国病人的疗效测试,以推进北美第一期第三阶段试验.
according to New Atlas这9个问题, 每个人都在问, 新的减肥药丸 来英国.
according to Daily Mail (Mail Online) - Home
Disputedincompatible versions — to verify
No factual contradiction detected between sources.
Framing by sidesame fact, different words — loaded terms highlighted
No notable framing divergence.
Blind spotwhat one side keeps silent
No blind spot detected: every side covers the same facts.
Sources2 sources cross-checked
Center1